RetinalGenix Technologies Income Statement (2020-2026) | RTGN

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Sep2020	Dec2020	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Operating items
Research & Development (Quarter)				0.16M	0.20M	0.18M	0.16M	0.14M	0.20M	0.32M	0.23M	0.15M	0.09M	0.05M	0.08M	0.08M	0.10M	0.10M	0.01M	0.01M	0.02M	0.03M	0.12M
Selling, General & Administrative (Quarter)				0.29M	0.29M	0.17M	0.16M	0.17M	0.20M	0.28M	0.20M	0.12M	0.17M	0.41M	0.33M	0.37M	0.24M	0.39M	0.34M	0.38M	0.27M	0.31M	0.26M
Other Operating Expenses (Quarter)				0.09M	0.06M	1.79M	-0.30M	0.06M	2.10M	0.08M	0.08M	0.08M	0.43M	0.08M	1.73M	0.21M	0.30M	0.37M	0.23M	0.25M	0.28M	0.28M	0.21M
Operating Expenses (Quarter)				0.53M	0.55M	2.14M	0.02M	0.36M	2.50M	0.67M	0.51M	0.35M	0.69M	0.54M	2.14M	0.66M	0.64M	0.87M	0.59M	0.65M	0.57M	0.62M	0.59M
Net income details
Profit After Tax (Quarter)				-0.53M	-0.55M	-0.41M	-0.38M	-0.36M	-2.50M	-0.67M	-0.51M	-0.35M	-0.69M	-0.54M	-2.15M	-0.66M	-0.64M	-0.87M	-0.59M	-0.65M	-0.57M	-0.62M	-0.59M
Additional items
EPS (Basic) (Quarter)				-0.01	-0.01	-0.01	-0.03	-0.02	-0.15	-0.04	-0.03	-0.02	-0.04	-0.03	-0.12	-0.04	-0.04	-0.05	-0.03	-0.03	-0.03	-0.03	-0.03
EPS (Weighted Average and Diluted) (Quarter)								-0.02	-0.15	-0.04	-0.03	-0.02	-0.04	-0.03	-0.12	-0.04	-0.04	-0.05	-0.03	-0.03	-0.03	-0.03	-0.03
Shares Outstanding (Weighted Average) (Quarter)				41.08M	41.03M	41.25M	14.28M	14.52M	15.13M	15.58M	17.27M	17.27M	17.28M	17.35M	17.67M	17.70M	17.87M	17.94M	18.52M	18.53M	18.54M	18.56M	18.75M
Shares Outstanding (Diluted Average) (Quarter)								14.52M	16.56M	15.58M	17.27M	17.27M	17.27M	17.35M	17.67M	17.86M	17.87M	17.94M	18.52M	18.33M	18.58M	18.56M	18.75M
Interest Expenses (Quarter)					0.00M	0.00M	0.00M	0.00M	0.00M	960.00	960.00	960.00	960.00	960.00	960.00	960.00	960.00	960.00	909.00	0.01M	958.00	0.00M	0.01M